CFTR and chronic obstructive pulmonary disease: Previous sputum proteomics studies have yielded valuable insights, yet with lower protein coverage; Yan et al. reported 280 proteins in COPD sputum, highlighting microbiome-host interactions21, while Maher et al. demonstrated CFTR modulator therapy-induced proteomic shifts, with 80 proteins increasing and 30 decreasing post-therapy18.